MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Spasticity: Genetics"

  • 2024 International Congress

    Spastic paraparesis and paroxysmal dystonia associated with a novel mutation in ATP1A3 in a spanish family

    FJ. Azcárate-Díaz, J. Herreros-Rodríguez, L. Llorente-Ayuso, S. Manzano, C. González González, P. Rábano-Suárez, T. Talaván, A. Esquivel (Madrid, Spain)

    Objective: To describe a new phenotype related to a novel mutation in ATP1A3 in two women from the same family Background: Mutations in ATP1A3 have…
  • 2024 International Congress

    Improving Work Up amongst Patients with Rare Movement Disorders according to Diagnostic Yield Findings– Update from Single Center Neurogenetic Clinic

    D. Penn, Y. Amir, G. Ben David, J. Zitser Koren, G. Gurevich, H. Baris Feldman, R. Alcalay, Y. Yaron, P. Ponger (Tel Aviv, Israel)

    Objective: We present the genetic testing diagnostic yield in a tertiary center Neurogenetic Clinic, focusing on rare movement disorders. Background: The diagnostic yield of genetic…
  • 2024 International Congress

    New Pathological Findings in an International Cohort of Hereditary Spastic Paraplegia 4 Patients

    A. Orlacchio, A. Meyyazhagan, P. Eusebi, P. Basavaraju, H. Kuchi Bhotla, M. Stasi, G. Ribas, I. Faber, R. Miyamoto, M. Miele, R. Massa, P. Patti, M. França Jr, J. Pedroso, O. Barsottini, H. Teive, T. Kawarai, E. Panza (Perugia, Italy)

    Objective: To determine the clinical and genetic differences in hereditary spastic paraplegia SPG4 patients across various countries. Background: SPG4/SPAST gene account for approximately 40% of…
  • 2024 International Congress

    A Patient with Overlapping SPG7 mutation and MERRF

    J. Patino, M. Koenig (Houston, USA)

    Objective: To describe the first case of concomitant spastic paraplegia type 7 (SPG7) and myoclonic epilepsy with ragged red fibers (MERRF) in a patient with…
  • 2024 International Congress

    Autosomal Recessive Spastic Ataxia Secondary a Novel SPG7 Gene Pathogenic Variant: a Case Report

    K. Salinas-Barboza, J. Altamirano, A. Armas-Salazar (CDMX, Mexico)

    Objective: The primary aim of this investigation is to describe a newly identified pathogenic variant within the SPG7 gene observed in a clinical presentation of…
  • 2024 International Congress

    Adult Onset Spastic Paraplegia in TUBB4A Leukodystrophy

    HJ. Kim, HJ. Ha, CY. Lee, JY. Yun (Seoul, Republic of Korea)

    Objective: Introduction: Leukodystrophies are primarily known as childhood diseases, but recent advances in genetic testing and brain imaging have led to an increase in reports…
  • 2023 International Congress

    Kufor-Rakef syndrome, report of two unrelated cases from Chile studied with DAT-PET

    P. Saffie, E. Fernandez, S. Mariacca, P. Salles, P. Chana (Santiago, Chile)

    Objective: To describe two previously unreported, unrelated cases of atypical parkinsonism caused by mutations in ATP13A2gene. Background: ATP13A2 gene, previously known as PARK 9, has recently…
  • 2023 International Congress

    Spinocerebellar ataxia type 28 presenting as spastic paraparesis

    R. Hoe, S. Neo, L. Tan (Singapore, Singapore)

    Objective: To describe a patient with spinocerebellar ataxia type 28 (SCA28) presenting with isolated spastic paraparesis. Background: Autosomal dominant (AD) mutations in the ATPase family…
  • 2023 International Congress

    Rare genetic and clinical presentation of SPG7-related Hereditary Spastic Paraplegia.

    J. Hickman, E. Forbes, J. Feuerstein (DENVER, USA)

    Objective: Describe a rare genetic and clinical presentation of SPG7-related Hereditary Spastic Paraplegia. Background: SPG7-related spastic paraplegia (SPG7) is a hereditary spastic paraplegia caused by…
  • 2023 International Congress

    Movement disorders spectrum in CTNNB1-related neurodevelopmental disorders

    G. Garone, M. Grasso, L. Travaglini, MC. Digilio, A. Capuano, F. Nicita, G. Della Bella, D. Diodato, L. Chioma, A. Mandarino, L. Sinibaldi (Rome, Italy)

    Objective: To describe the phenomenology and clinical course of movement disorders in CTNNB1-related neurodevelopmental disorder (CTNNB1-NDD). Background: CTNNB1-NDD is a rare neurogenetic condition caused by…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • …
  • 9
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley